A. Shulman et al., In-vitro fertilization treatment for severe male factor: the fertilizationpotential of immotile spermatozoa obtained by testicular extraction, HUM REPR, 14(3), 1999, pp. 749-752
A retrospective analysis in 50 couples of 53 cycles of intracytoplasmic spe
rm injection (ICSI) with immotile spermatozoa from testicular-retrieved spe
rmatozoa was performed to evaluate whether total immotile spermatozoa achie
ved after testicular sperm extraction could fertilize ova and result in pre
gnancies. We assessed the efficacy of ICSI with totally immotile testicular
spermatozoa extracted from the testes of azoospermic patients with severe
spermatogenic failure (group 1) and compared these results with those from
spermatozoa which were recovered after several hours of incubation and were
motile (group 2) at the time of injection. In 19 cycles, only totally immo
tile spermatozoa were injected at the time of ICSI, For the remaining 34 cy
cles, at least one motile spermatozoon was found for injection, The oocyte
fertilization rates were 51% for group 1 and 62% for group 2 (P < 0.02). Ei
ghteen of 19 cycles in group 1 (90%) and all 34 (100%) cycles in group 2 ha
d embryos for replacement. The mean number of embryos per cycle was 5.2 +/-
0.8 and 7.5 +/- 0.9 in groups 1 and 2 respectively; this and the embryo qu
ality (cumulative embryo scoring = 40 +/- 8 for group 1 and 50 +/- 7 for gr
oup 2), and clinical pregnancy rates (15.8% per oocyte retrieval in group 1
and 23.5% in group 2) were not significantly different between groups. Fer
tilization, cleavage and pregnancy can be achieved with intracytoplasmic te
sticular sperm injection from patients with immotile spermatozoa, at levels
comparable with those of ICSI using motile spermatozoa.